2,659
Views
29
CrossRef citations to date
0
Altmetric
Review

A critical literature review of health economic evaluations of rotavirus vaccination

, , , , &
Pages 1272-1288 | Received 26 Nov 2012, Accepted 10 Mar 2013, Published online: 09 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Monica Tafalla, Dace Gardovska, Kusuma Gopala & Liga Kozlovska. (2019) Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis. Human Vaccines & Immunotherapeutics 15:6, pages 1272-1278.
Read now
G. Gervasi, A. Capanna, V. Mita, L. Zaratti & E. Franco. (2016) Nosocomial rotavirus infection: An up to date evaluation of European studies. Human Vaccines & Immunotherapeutics 12:9, pages 2413-2418.
Read now
Carla D Scarbrough Lefebvre, Augustin Terlinden & Baudouin Standaert. (2015) Dissecting the indirect effects caused by vaccines into the basic elements. Human Vaccines & Immunotherapeutics 11:9, pages 2142-2157.
Read now
Catherine Weil-Olivier, Aurélie Millier, Mondher Toumi & Mélanie Trichard. (2014) Population access to rotavirus vaccination in industrialized countries: lessons learnt from current experience. Expert Review of Vaccines 13:11, pages 1405-1417.
Read now
Bernd Brüggenjürgen, Mathie Lorrot, Fiona R Sheppard & Vanessa Rémy. (2014) Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe?. Human Vaccines & Immunotherapeutics 10:8, pages 2290-2294.
Read now
. (2013) Landes Highlights. Gut Microbes 4:4, pages 265-266.
Read now

Articles from other publishers (23)

Tim Jesudason, Alejandra Rodarte, David Tordrup, Cristina Carias & Yao-Hsuan Chen. (2023) Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques. Vaccine 41:36, pages 5221-5232.
Crossref
Javier P Gisbert & María Chaparro. (2023) Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe? . Journal of Crohn's and Colitis 17:6, pages 995-1009.
Crossref
Aileen Murphy, Ann Kirby & Federica De Blasio. (2023) The economic impact of the introduction of universal rotavirus vaccination on rotavirus gastroenteritis related hospitalisations in children in Ireland. Vaccine 41:16, pages 2656-2663.
Crossref
Eric I. Benchimol, Frances Tse, Matthew W. Carroll, Jennifer C. deBruyn, Shelly A. McNeil, Anne Pham-Huy, Cynthia H. Seow, Lisa L. Barrett, Talat Bessissow, Nicholas Carman, Gil Y. Melmed, Otto G. Vanderkooi, John K. Marshall & Jennifer L. Jones. (2021) Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines. Gastroenterology 161:2, pages 669-680.e0.
Crossref
Eric I Benchimol, Frances Tse, Matthew W Carroll, Jennifer C deBruyn, Shelly A McNeil, Anne Pham-Huy, Cynthia H Seow, Lisa L Barrett, Talat Bessissow, Nicholas Carman, Gil Y Melmed, Otto G Vanderkooi, John K Marshall & Jennifer L Jones. (2021) Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology 4:4, pages e59-e71.
Crossref
Frédéric Debellut, Andrew Clark, Clint Pecenka, Jacqueline Tate, Ranju Baral, Colin Sanderson, Umesh Parashar & Deborah Atherly. (2021) Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. The Lancet Global Health 9:7, pages e942-e956.
Crossref
Florian Zeevat, Evgeni Dvortsin, Abrham Wondimu, Jan C. Wilschut, Cornelis Boersma & Maarten J. Postma. (2021) Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost. Vaccines 9:2, pages 144.
Crossref
Teruyoshi Kurosawa, Hiroshi Watanabe & Kenzo Takahashi. (2020) Cost-utility Analysis of Rotavirus Vaccines Including the Latest Evidence and Data as of June 2020 in Japan. Pediatric Infectious Disease Journal 40:2, pages 162-168.
Crossref
Baudouin Standaert, Christophe Sauboin, Quentin J. Leclerc & Mark P. Connolly. (2020) Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. PharmacoEconomics 39:2, pages 257-269.
Crossref
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Dirk Poelaert, Priya Pereira, Robert Gardner, Baudouin Standaert & Bernd Benninghoff. (2018) A review of recommendations for rotavirus vaccination in Europe: Arguments for change. Vaccine 36:17, pages 2243-2253.
Crossref
Natalie Carvalho, Mark Jit, Sarah Cox, Joanne Yoong & Raymond C. W. Hutubessy. (2017) Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. PharmacoEconomics 36:1, pages 79-90.
Crossref
Sue E. Crawford, Sasirekha Ramani, Jacqueline E. Tate, Umesh D. Parashar, Lennart Svensson, Marie Hagbom, Manuel A. Franco, Harry B. Greenberg, Miguel O'Ryan, Gagandeep Kang, Ulrich Desselberger & Mary K. Estes. (2017) Rotavirus infection. Nature Reviews Disease Primers 3:1.
Crossref
Amal Y.A. Al-Aidaroos, Baudouin Standaert, Kinga Meszaros & Atef M. Shibl. (2017) Economic assessment of rotavirus vaccination in Saudi Arabia. Journal of Infection and Public Health 10:5, pages 564-571.
Crossref
Christina Hansen Edwards, Birgitte Freiesleben de Blasio, Beatriz Valcárcel Salamanca & Elmira Flem. (2017) Re–evaluation of the cost–effectiveness and effects of childhood rotavirus vaccination in Norway. PLOS ONE 12:8, pages e0183306.
Crossref
Shuhui Cui, Ruoyan Gai Tobe, Xiuting Mo, Xiaoyan Liu, Lingzhong Xu & Shixue Li. (2016) Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option. BMC Infectious Diseases 16:1.
Crossref
Joseph D. Njau & Lisa K. Cairns. (2016) A literature review on the economic benefits of vaccines in low and middle income countries: Evaluating progress in the era of ‘a decade of vaccines’ initiative. Vaccine Reports 6, pages 62-76.
Crossref
Kittiphong Thiboonboon, Benjarin Santatiwongchai, Varit Chantarastapornchit, Waranya Rattanavipapong & Yot Teerawattananon. (2016) A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines. Applied Health Economics and Health Policy 14:6, pages 659-672.
Crossref
Mark Jit & Raymond Hutubessy. (2016) Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?. Applied Health Economics and Health Policy 14:3, pages 245-252.
Crossref
Stef Lemmens, Catherine Decouttere, Nico Vandaele & Mauro Bernuzzi. (2016) A review of integrated supply chain network design models: Key issues for vaccine supply chains. Chemical Engineering Research and Design 109, pages 366-384.
Crossref
. 2016. Molecular Microbiology. Molecular Microbiology 362 385 .
Stephen B. Freedman, Bonita E. Lee, Marie Louie, Xiao-Li Pang, Samina Ali, Andy Chuck, Linda Chui, Gillian R. Currie, James Dickinson, Steven J. Drews, Mohamed Eltorki, Tim Graham, Xi Jiang, David W. Johnson, James Kellner, Martin Lavoie, Judy MacDonald, Shannon MacDonald, Lawrence W. Svenson, James Talbot, Phillip Tarr, Raymond Tellier & Otto G. Vanderkooi. (2015) Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): epidemiology, emerging organisms, and economics. BMC Pediatrics 15:1.
Crossref
Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk & Baudouin Standaert. (2013) Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?. Health Economics Review 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.